Herpes simplex virus type 1 infection of corneas can lead to blinding
inflammation in the corneal stroma, which is referred to clinically as
herpes stromal keratitis. In our mouse model of this prevalent human
disease, a heavy polymorphonuclear neutrophil (PMN) infiltration of th
e infected cornea leads to progressive tissue destruction. This inflam
matory process can be abrogated by in vivo depletion of CD4 T lymphocy
tes and by neutralization of the cytokines IL-2 and IFN-gamma. The goa
l of this study was to define the mechanisms by which IL-2 mediates th
e corneal inflammation, Systemic neutralization of IL-2 after the onse
t of corneal disease resulted in a rapid regression of inflammation an
d complete resolution in 50% of the treated mice. The disease remissio
n was associated with loss of IFN-gamma expression in the cornea, as d
etermined by immunohistochemistry, and a significant reduction of IFN-
gamma mRNA, as measured by a semiquantitative reverse transcription-PC
R analysis. Within 48 h after anti-IL-2 mAb administration, the PMN ch
emotactic gradient in the infected corneas was abolished, and those PM
N that were already present in the central cornea exhibited clear sign
s of apoptotic cell death. Our results demonstrate that IL-2 mediates
corneal inflammation by 1) regulating local IFN-gamma production in an
autocrine or a paracrine fashion, 2) establishing a PMN chemotactic g
radient, and 3) maintaining PMN viability in the cornea, These results
suggest that IL-2 might be targeted for therapeutic intervention in t
his blinding disease.